Form 4: AngioDynamics Director Donnelly Receives Stock Grant as Annual Compensation

Director Howard W. Donnelly acquired 20,541 shares of AngioDynamics common stock as part of his annual compensation.

Summary

• Howard W. Donnelly, a director at AngioDynamics Inc., acquired 20,541 shares of common stock on July 17, 2024.
• The acquisition was a grant of restricted stock units, representing annual compensation for his service as a director.
• The restricted stock units vested immediately upon grant.
• Following the transaction, Donnelly beneficially owns 149,376 shares of AngioDynamics.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects standard director compensation practices, indicating stability and alignment of interests.

Positives

• The grant of stock units to a director aligns their interests with those of the shareholders.
• Immediate vesting of the restricted stock units provides an immediate incentive for the director.

Industry Context

Director compensation in the form of stock grants is a common practice in publicly traded companies to align the interests of directors with those of shareholders. The size of the grant is typical for director-level compensation.

Comparison to Industry Standards

• Stock grants for board members are a common practice across the industry.
• Companies like Medtronic and Boston Scientific also use stock options and restricted stock units as part of their director compensation packages.
• The value of the grant is consistent with industry standards for companies of AngioDynamics' size and market capitalization.

Stakeholder Impact

• Shareholders may view the stock grant positively as it aligns the director's interests with the company's performance.
• Employees may see this as a sign of stability and commitment from the board.

Key Dates